Home » Reimann on changes to the Medicines Act: “Sensitive weakening of the …

Reimann on changes to the Medicines Act: “Sensitive weakening of the …

by admin
Reimann on changes to the Medicines Act: “Sensitive weakening of the …

20.06.2023 – 15:50

AOK Federal Association

Berlin (ots)

Regarding the amendments to the Medicines Supply Bottleneck Combating and Supply Improvement Act (ALBVVG) announced today, the chairwoman of the AOK Federal Association, Dr. Carola Reimann:

“On the home straight to legislation, the specifications for tendering options for drug discount agreements will be made even worse and thus the cost-effectiveness of drug supply will be severely weakened. The Federal Ministry of Health, in cooperation with the Federal Institute for Drugs and Medical Devices (BfArM), should in future use non-described characteristics of an imminent or existing market concentration and, on this basis, can in turn extend the new tendering regulations, which were last planned for antibiotics, to other drug groups.

Discount agreements stabilize the supply chain and thus demonstrably strengthen the security of supply. Effective and safe drug discount agreements save billions of dollars each year for the contributor community. The now planned further softening of the tendering system is carelessly jeopardizing these savings. It is naïve to assume that the planned changes will not result in any additional expenditure for statutory health insurance.

Shortly after the contribution increases announced by Minister Lauterbach, legal regulations are now also being pushed that will lead to additional expenditure and further burdens for those paying contributions.”

Press contact:

Your contact person in the press office:
Dr. Kai Behrens
Phone: 030 / 34646-2309
Mobil: 01520 / 1563042
E-Mail: [email protected]

Original content from: AOK Federal Association, transmitted by news aktuell

See also  MAK SYSTEM ANNOUNCES STRATEGIC RELATIONSHIP WITH AWS FOR THE LAUNCH OF MAK.care

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy